Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Jerash Holdings (US) (JRSH) EBITDA (2016 - 2025)

Jerash Holdings (US)'s EBITDA history spans 10 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, EBITDA rose 935.02% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $2.0 million, up 145.84%, while the annual FY2025 figure was -$860732.0, 64.3% up from the prior year.
  • EBITDA reached $1.2 million in Q4 2025 per JRSH's latest filing, up from $444390.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $4.4 million in Q3 2021 to a low of -$3.4 million in Q1 2024.
  • Average EBITDA over 5 years is $480327.0, with a median of $423128.5 recorded in 2023.
  • Peak YoY movement for EBITDA: skyrocketed 1445.74% in 2021, then plummeted 1659.53% in 2023.
  • A 5-year view of EBITDA shows it stood at $1.7 million in 2021, then tumbled by 45.92% to $928622.0 in 2022, then crashed by 65.55% to $319884.0 in 2023, then plummeted by 145.88% to -$146775.0 in 2024, then surged by 935.02% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for JRSH's EBITDA are $1.2 million (Q4 2025), $444390.0 (Q3 2025), and $328240.0 (Q2 2025).